New daily pill for weight loss enters first human tests
NCT ID NCT07307638
First seen Jan 11, 2026 · Last updated May 12, 2026 · Updated 19 times
Summary
This early-stage study tested a new daily pill, ZT006, in 94 healthy, overweight, and obese adults. The main goal was to check safety and how the drug moves through the body, not to prove weight loss. Participants received either the drug or a placebo, and some took it with food to see if meals affect absorption. The study is complete, and results will guide future research.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERWEIGHT , OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Second Affiliated Hospital of Anhui Medical University
Hefei, Anhui, 230601, China
Conditions
Explore the condition pages connected to this study.